Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of €52.26 billion as of September 19, 2025. Its market cap has decreased by -54.50% in one year.

Market Cap

52.26B

Enterprise Value

39.64B

Revenue

12.10B

Ranking

n/a

PE Ratio

13.77

Stock Price

€505.40

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 52.26B, an increase of 39,668.86%. That is a compound annual growth rate of 19.76%.

Market Cap History

Date	Market Cap	% Change
Sep 19, 2025	52.26B	-29.40%
Dec 31, 2024	74.03B	-12.40%
Dec 29, 2023	84.50B	17.20%
Dec 30, 2022	72.10B	24.19%
Dec 31, 2021	58.06B	39.28%
Dec 31, 2020	41.68B	13.96%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	265.00B
Siemens Aktiengesellschaft	177.21B
Deutsche Telekom AG	138.87B
Allianz SE	132.25B
Rheinmetall AG	88.46B
Siemens Energy AG	81.14B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	67.41B
Deutsche Bank Aktiengesellschaft	59.22B

Market Cap Rankings